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ORIGINAL ARTICLE
Supercoiled Minivector DNA resists shear forces associated
with gene therapy delivery
DJ Catanese Jr1,2,3, JM Fogg1,2,3, DE Schrock II1,4, BE Gilbert1 and L Zechiedrich1,2,3,4
Supercoiled DNAs varying from 281 to 5302bp were subjected to shear forces generated by aerosolization or sonication. DNA
shearing strongly correlated with length. Typical sized plasmids (X3000bp) degraded rapidly. DNAs 2000–3000bp persisted
B10min. Even in the absence of condensing agents, supercoiled DNA o1200bp survived nebulization, and increased forces
of sonication were necessary to shear it. Circular vectors were considerably more resistant to shearing than linear vectors of the
same length. DNA supercoiling afforded additional protection. These results show the potential of shear-resistant Minivector
DNAs to overcome one of the major challenges associated with gene therapy delivery.
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INTRODUCTION
There are currently many challenges to gene therapy and most involve
hurdles with nucleic acid delivery. Althoughviruses are highly effective
and deliver high doses, they can trigger immunological and inﬂam-
matory responses and can potentially misregulate endogenous genes.
Such responses may result in disease or even death.1–4 Because of these
problems, effort has been expended toward the development of
effective non-viral vectors.5 Plasmid DNA vectors are relatively inex-
pensive, easy to make and store, and have tremendous design capacity.
A shortcoming of plasmids is their size (typically 44000 base
pairs (bp)), which makes them highly susceptible to shear-induced
degradation.6,7
Another important challenge of gene therapy is targeting the vector
to the diseased organ. The lungs are amenable to gene therapy because
they are accessible through the nose and mouth. Nebulization to create
an aerosol is routinely used to deliver drugs for the treatment of lung
diseases. Although toxicity is lessened when plasmid DNA is delivered
by aerosol compared with systemic delivery,8,9 plasmid DNA still
cannot be delivered by this method because of extensive degrada-
tion.10,11 DNA degradation during nebulization is thought to mainly
occur because of hydrodynamic shear,12 which is the force exerted on
the DNA by the rapid ﬂow of the solvent.
DNA degradation by hydrodynamic shear was ﬁrst studied over 50
years ago by forcing bacteriophage DNA through a hypodermic
needle.13 Although several studies since have attempted to determine
the mechanisms behind DNA shearing, it is still not fully understood
what causes the DNA to degrade.7 Many vehicle systems have been
developed to try to protect fragile plasmid vectors (or synthetic small
interfering RNA) from delivery-associated shear forces. The cationic
agents, polyethylenimine, polylysine, polyamines, and liposomes act to
condense and shield the DNA. They protect the DNA from shearing
by reducing the hydrodynamic diameter of the molecule.12,14
However, these vehicles are highly cytotoxic and pro-inﬂamma-
tory,15,16 and only partially alleviate DNA shearing.17,18
For the few cases in which the effect of DNA size has been studied,
shear force resistance is inversely correlated with DNA length;
13000bp plasmids were more resistant to shearing than 20000 or
29000bp plasmids measured in a rotary disk shearing device6 and
9800bp plasmids sheared three times more rapidly than 5000bp
plasmids in a jet nebulizer.12 It is reasonable to extrapolate that shorter
DNAvectors should be less vulnerable to shearing, but this idea could
not be tested previously because it was not possible to generate shorter
circular DNA (o2000bp) in sufﬁcient quantities to do the experi-
ments. Because of the need for a bacterial origin of replication and a
selectable marker, thousands of bp are required for the propagation
of plasmids.5 Deleting such sequences, through site-speciﬁc recombi-
nation, results in DNA vectors that are less toxic and less likely to
be silenced than plasmids.19,20 Still thousands of bp in length,
however, these ‘Minicircles’ remain highly susceptible to shear-
induced degradation.
A potential way to make smaller DNA vectors is to ligate linear
DNAs in vitro. Depending on sequence, shortening DNA makes it
increasingly difﬁcult to bend into a circle because of inherent
rigidity.21–23 Thus, obtaining reasonable quantities of circles less
than 1000bp is difﬁcult; microgram quantities were previously the
best achievable yields.24 Manipulating DNA supercoiling through
topoisomerase mutations and using site-speciﬁc recombination in
Escherichia coli, we generate Minivectors as small as B250bp in
milligram quantities.25,26 Nearly devoid of bacterial sequences, Mini-
vectors can be used to express short hairpin RNA (shRNA), micro-
RNA (miRNA) or genes in various cell types, including cells that are
refractory to plasmid transfection.26 In this paper, we use Minivectors
to determine the role of DNA length, circularity, and supercoiling on
shear force resistance. We ﬁnd that extrapolation from the previous
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RESULTS
Shearing as a function of DNA length
There are multiple ways to generate hydrodynamic shear: passage
through a narrow gauge needle, circulation through high-performance
liquid chromatography tubing, nebulization, and sonication.27 We
used nebulization because it is both highly reproducible and clinically
relevant. In a Collison-like jet nebulizer,28 it is far easier to collect
samples from the reservoir, and DNA degradation was identical when
sampled from the aerosol or the reservoir (Supplementary Figure 1).
For the experiments described below, therefore, we sampled from the
reservoir.
Supercoiled DNAs varying from 281 to 5302bp (Table 1) were
subjected to nebulization and their survival was analyzed by gel
electrophoresis (Figure 1). The extent of DNA shearing was quantiﬁed
by measuring the disappearance of intact DNA vector over time. The
ability to withstand shear forces in the nebulizer was, in general,
inversely correlated with DNA length. Supercoiled DNA vectors
42600bp, the size range of DNA vectors used previously for delivery,
fragmented completely and rapidly and displayed pseudo-exponential
decay (Figure 1b). The sigmoid shape of the decay curves for super-
coiled DNA vectors between 1580 and 2232bp showed an initial
resistance to shearing followed by degradation (Figure 1b), a very
different behavior from that of the larger vectors. In common, all
DNA vectors sheared into fragments that ranged from 200 to 1000bp
(Figure 1a). Supercoiled Minivectors p1243bp slightly concentrated
with time in the nebulizer because of evaporation (Figure 1b). To
address whether changing DNA concentrations could affect shear force
survival, solutions of 1873bp plasmid ranging from 1 to 10mgml  1
were nebulized. The decay kinetics were identical at all concentrations
(data not shown).
To facilitate comparisons among the differently sized DNA vectors,
we introduce a term, Survival50, which is the time at which 50% of
intact vectors remain. Nebulization Survival50 as a function of DNA
vector length is shown (Figure 1c). Comparing the data in this way
revealed important and unexpected results. First, Survival50 did not
depend monotonically on DNA length, but instead exhibited a thresh-
old-like behavior as deﬁned by the asymptote. Below this threshold,
which may reﬂect a critical hydrodynamic diameter, DNA vectors did
not appreciably shear. Second, Minivectors survived better than
plasmids of the same length.
There are several differences between plasmids and Minivectors.
Plasmids contain origins of replication and genes encoding antibiotic
resistance; Minivectors contain attR.25 In addition, different bacterial
strains are used for the propagation of plasmids and Minivectors.25,26
As a consequence, Minivectors have increased supercoiling
(s B 0.09 compared with s B 0.075 for plasmids29), which should
further decrease their hydrodynamic diameter, and this may explain
their increased protection from shear forces. To address the potential
effect of increased supercoiling, we propagated a plasmid or a
Minivector of the same length in LZ54,30 the bacterial strain used to
generate Minivectors. The 1711bp plasmid, pDJC1, propagated in
LZ54 persisted as long as the 1714bp Minivector (Figure 1c, compare
open circle with closed circle, arrow). Plasmid pQR499 (1873bp)
isolated from LZ54 also persisted longer than when it had been
propagated in DH5a (Figure 1c, arrow). Increased supercoiling,
therefore, and not differences in sequence between plasmids and
Minivectors, accounted for the increased shear resistance.
The advantages of reducing vector size were even more pronounced
when Survival90, the time at which 90% of vectors remained, was
Table 1 DNA vectors used in this study
Length (bp) DNA vector Encodesa Nebulization Survival50 (min) Sonication Survival50 (min) Reference or source
281 mv281 — 430 ND 25
336 mv336 — ND 96.13±2.95 This study
383 mv-H1-GFPshRNA shRNA to eGFP 430 ND 26
562 Dimer of mv281 — 430 ND 25
672 Dimer of mv336 — 430 21.86±3.68 This study
985 mv-H1-miR31 Human miR-31 430 ND This study
999 mv999 — ND 5.98±1.46 25
1109 mv-KB4TAL-GLuc Gaussia luciferase 430 ND This study, Nanolight Technology
1243 mv-KB4TAL-mCherry mCherry 430 3.73±0.55 This study53
1580 mv-CMV-GLuc Gaussia luciferase 32.3±3.1 1.77±0.69 This study, Nanolight Technology
1711 pDJC1 — 21.6±3.2
28.2±3.4b
ND This study
1714 mv-CMV-mCherry mCherry 27.5±2.3 ND This study53
1873 pQR499 — 22.0±1.1
24.4±1.3b
0.85±0.10 54
2067 pINV2067 — 19.1±0.2 ND Invitrogen supercoiled DNA ladder
2232 pAO — 16.6±3.5 ND 55
2679 mv-CMV-Luc2 Fireﬂy luciferase 9.6±1.5 ND This study, Promega
2686 pUC18 — 10.8±1.4 ND Novagen Inc.
3000 pBLUESCRIPT — 6.1±0.1 ND Stratagene
3459 pJB3.5i attB, attP 3.4±0.9 ND 56
3869 pMC339-BbvCI attB, attP 4.0±0.5 0.17±0.04 25
5302 pCR2.1-norE norE 1.5±0.1 ND This study
Abbreviations: eGFP, enhanced green ﬂuorescent protein; miR, microRNA; ND, not determined; shRNA, short hairpin RNA.
aAll Minivectors contain attR;25 all plasmids encode bla.
bPropagated in LZ54.
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Gene Therapyconsidered (Figure 1c, inset). Below 3000bp, there was a very steep
inverse correlation between DNA length and Survival90 values. For
DNA vectors o2000bp, Survival90 values were longer than 10min, as
a result of the initial resistance to shearing and as seen by the
sigmoidal decay. Considering various percentages of DNA vector
survival might be useful for calculating the relative beneﬁts and
risks of using a particular DNAvector length (Supplementary Table 1).
Effect of DNA circularity and supercoiling on shear force resistance
To better understand the contribution of DNA supercoiling to shear
force resistance, we compared linear, nicked and relaxed forms of the
vectors (Figure 2). Half of the negatively supercoiled 1873bp plasmid,
pQR499, survived 22min, longer than either the relaxed, open-
circular (17.5min) or nicked (17.2min) forms of the vector. The
nearly identical Survival50 values of the nicked and relaxed plasmids
revealed, somewhat unexpectedly, that a single-strand break does not
signiﬁcantly weaken this vector during nebulization. Circularity
had a bigger impact on Survival50 than supercoiling did; half of the
linear form of the 1873bp DNA was sheared in B4min. The fragility
of linear DNA during nebulization was the same whether the ends
were blunt, had 2-base 3¢-overhangs or had 4-base 5¢-overhangs (data
not shown); therefore, the nature of the ends did not affect DNA
shearing.
Because shorter vectors completely survived nebulization, we used
sonication to determine how supercoiling affected their shearing. Like
nebulization, sonication also generates highly reproducible shear
forces, but these forces can be much greater and can be generated
for longer periods of time. The difference in the shear force magnitude
is exempliﬁed by the differences in Survival50 values between the
supercoiled 3869bp plasmid (sonication Survival50¼0.17min and
nebulization Survival50¼4min) and the 1873bp plasmid (sonication
Survival50¼0.85min and nebulization Survival50¼22min). Despite
the difference in shear force magnitude, the two methods for shearing
yielded the same general result—a strong correlation of DNA vector
length and shearing (Figure 3). For example, the 3869bp plasmid
was sheared 4500 times more rapidly (Survival50¼0.17min) than a
vector approximately one-tenth that length, the 336bp Minivector
(Survival50¼96min).
Figure 1 DNA survival during nebulization as a function of DNA length. (a) Representative gels of DNA vectors subjected to nebulization as sampled from
the reservoir. (b) Graphical representation of DNA shearing as a function of length (averaged for at least three separate experiments). The curves represent
the ﬁt to a sigmoidal function (Supplementary Table 1). Minivectors p1243bp were not ﬁtted because after 30min the intact DNA did not decrease.
Nebulization survival times were determined for each DNA vector. (c) The time at which 50% of the vector survived (Survival50). Each Survival50 value is the
mean from at least three separate experiments. Error bars represent the standard deviation. The arrows denote Survival50 of the two plasmids, pDJC1 and
pQR499, that were propagated in LZ54. Minivectors are represented by open circles and plasmids are shown as closed circles. The inset shows Survival90
values, which is the time at which 90% of vectors remained.
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Gene TherapyIt was impossible to distinguish Survival50 by sonication for the
circular forms of the 1873bp plasmid, which were all about a minute,
but the value for the linear form was only 0.2min. Although the DNA
vectors could be subjected to sonication much longer than they could
to nebulization, sonicating DNA for more than 90min is impractical.
Therefore, to determine how DNA supercoiling affected shear force
survival required a balance between a Minivector large enough for
differences to be detected and small enough for those differences to be
separated. A 999bp Minivector ﬁt these criteria. Like the 1873bp
plasmid sheared by nebulization, this Minivector sheared according to
its topology; linear sheared with a sonication Survival50¼0.8min,
nicked¼3.8min, relaxed¼4.6min and supercoiled¼6min.
With regard to shear force resistance, circularity is the most
important property of a DNA vector for protection. This protection
is B4- to 6-fold when comparing the nicked/relaxed and linear forms
of each vector (Figure 2). Supercoiling provides additional protection
from shear forces. The supercoiled 999 and 1873bp DNA vectors
persisted 58 and 28% longer, respectively, than their nicked counter-
parts (Figure 2).
DISCUSSION
Model for DNA shearing
Early studies of DNA shearing showed that the hydrodynamic shear
force exerted on a DNA molecule increases with the square of
the hydrodynamic diameter (the length-dependent diameter of the
DNA molecule in the ﬂuid stream).12,31 Our data are consistent with
this relationship. Circularity, decreasing length and increasing super-
coiling, properties that we ﬁnd to protect DNAvectors from shearing,
should all reduce hydrodynamic diameter. Intuitively, the hydrody-
namic diameter of a circular DNAvector should be approximately half
the length of the linear form,7 and this idea is supported by experi-
mental data.32 Our ﬁndings that the 1873bp linear DNA sheared as
rapidly as the 3869bp supercoiled plasmid and that the linear 999bp
DNA sheared comparably to a plasmid roughly twice its length is
consistent with this concept. In addition, our observation that super-
coiling affords additional protection is supported by the increased
survival of supercoiled DNA vectors compared with the nicked or
relaxed forms of the same length.
Because smaller DNA vectors experience less force, they survive
longer, but what ﬁnally makes them break? If single-stranded breaks
were generated, we would expect to see a transient appearance of
nicked intermediate as supercoiled DNA is sheared. Nicked DNA,
however, was not observed during shearing of the supercoiled vectors,
indicating that shearing generates primarily double-stranded breaks.
The absence of any full-length linear degradation products indicates
that following the initial double-strand break, additional breaks occur
in rapid succession, consistent with the extremely rapid conversion of
linear vectors to smaller fragments.
The pronounced lag observed before the smaller DNA vectors
degraded indicates that the shear forces in the nebulizer must not
initially be harsh enough to break these smaller vectors, and that the
continuous re-circulation of the DNA vectors may stretch or contort
them into a conformation that is then more susceptible to shearing.
There are two proposed competing effects of DNA supercoiling on
shear survival: torsional strain, which might make the molecule more
susceptible to shearing, and DNA compaction, which should make the
molecule more resistant to shearing.7 Although our data clearly show
that the beneﬁcial effect of compaction is the dominant effect,
torsional stress-induced deformation of DNA33–35 may contribute to
the eventual shearing of the vectors, thereby counteracting the
protective effect of supercoiling-mediated DNA compaction. As the
Figure 2 Effect of DNA topology on DNA survival. (a) How topology of plasmid DNA (1873bp) inﬂuences its survival during nebulization. The fraction of
DNA vector of each topology over time (averaged from at least three experiments) is shown. The curves are shown ﬁtted to a sigmodial function. (b)H o w
topology of Minivectors (999bp) inﬂuences its survival during sonication. The fraction of DNA was quantiﬁed the same as in (a).
Figure 3 DNA survival during sonication as a function of DNA length.
Because more force was necessary to degrade the smaller Minivectors,
sonication was employed. Sonication survival times were determined for
each DNA vector in the same manner as for nebulization in Figure 1. The
plot shows the time at which 50% of each vector survived (Survival50)
versus its length. Each Survival50 value is the mean from at least three
separate experiments. Error bars represent the standard deviation.
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Gene Therapyreservoir volume decreases, the rate of recirculation increases
(Supplementary Figure 2), consequently the frequency of exposure
to shear forces increases, and there may be less time for DNA to
recover from shear force-induced contortion. The stretched, contorted
and weakened DNA is then sheared more readily. This model predicts
that DNA base pair steps that are more likely to contort would be the
weak points of the molecule that shear. It is possible that the
nebulization protocol during treatment of a patient could be altered
to decrease this frequency of recycling, perhaps as simply as by
maintaining a constant reservoir volume.
Therapeutic consequences of DNA shearing
The most obvious detriment of DNA shearing is a reduction in the
amount of intact vector remaining for therapy. Larger DNA vectors
completely degrade into small fragments over the course of nebuliza-
tion. These fragments are presumably unable to elicit a therapeutic
effect as the transgene or shRNA together with the promoter are
destroyed. It might be tempting to increase the DNA dose to
compensate for this loss. Doing so, however, could have negative
consequences. First, increasing the amount of DNA vector would also
require a commensurate increase in the amount of toxic delivery
vehicle. Second, delivery of increased degraded DNA fragments could
induce DNA repair and recombination pathways or trigger apoptosis.
Third, cells could randomly ligate the fragmented DNA. Although
there is the potential of the ligations forming large episomal con-
catemers that could persist to cause stable long-term transgene
expression,36 there is also the possibility that the randomly ligated
DNA fragments could join together to generate new, potentially toxic
sequences. One way to avoid these problems would be to halt
nebulization earlier. For example, DNA vectors o2000bp, for which
Survival90 values were greater than 10min, could be halted after
10min. Shortening nebulization treatments would not be necessary
for the smaller Minivectors (o1000bp) because very little shearing
occurs, even after 30min.
DNA vector delivery to the lungs
Identifying DNAvector lengths that survive shear forces has important
implications for gene therapy delivery no matter what the delivery
route; however, the use of a Collison-like jet nebulizer makes our data
particularly germane for the consideration of DNA delivery to the
lungs. The lungs are readily accessible by intratracheal, intranasal and
aerosol delivery methods, and any of these routes is amenable to DNA
vector delivery. Aerosol delivery, in particular, is non-invasive, delivers
directly to the affected tissue and may help prevent off-target com-
plications. In addition, aerosol delivery allows DNA to be delivered to
the lungs in much higher quantities than systemic administration.37
A number of promising gene therapy targets have been identiﬁed
for the treatment of pulmonary diseases. Dozens of clinical trials are
ongoing that target, for example, cystic ﬁbrosis (http://www.wiley.
com/legacy/wileychi/genmed/clinical/). Disappointingly, however,
these existing therapies have so far been unsuccessful.38 Asthma as a
disease target has high potential for therapeutic RNA interference,
including shRNA39 and miRNA,40 but the bottleneck for success for
treatment of asthma is the same as for other diseases—delivery of the
nucleic acid therapy. The observation that Minivectors can overcome
some of the most difﬁcult obstacles associated with delivery renews
enthusiasm for gene therapy for the lungs.
Additional therapeutic beneﬁts of small, supercoiled DNA vectors
In a previous study from our group, Minivectors of 383bp, encoding
an shRNA against a pathogenic protein in lymphoma, survived intact
in human serum for 448h, whereas synthetic small interfering RNA
and plasmids were degraded within a couple of hours.26 Certain DNA
sequences, such as polyA signals and antibiotic resistance genes that
are commonly found in DNA vectors, are particularly susceptible to
attack by nucleases.41 Some of the biostability of Minivectors in the
serum may be a consequence of such sequences being absent from the
Minivectors.
Extra DNA on traditional plasmids contain bacterial sequences that
induce immunotoxic responses, primarily because of immune
responses to CpG motifs42 that are approximately four times more
prevalent in bacterial than mammalian DNA.43 In addition to toxicity,
bacterial sequences also induce transcriptional silencing of episomal
transgenes.44 ‘Minicircles’ that lack bacterial sequences exhibit sig-
niﬁcantly increased transgene expression.20,44,45
In addition to increased shear force survival, reducing the length of
DNA vectors also improves cell transfection.26,46,47 Minivectors of a
few hundred bp transfect cells that are refractory to transfection with
conventional plasmids.26 The smaller size of Minivectors means more
copies per unit mass. This fact, coupled with the very high transfection
efﬁciency,26 suggests that a lower DNA vector dose and, consequently,
less toxic transfection vehicle may be used.
Our data show that survival of shear forces associated with
nebulization requires DNA vectors to be circular and shorter than
2000bp. Although it may seem that therapeutically useful Minivectors
may express only shorter sequences, such as shRNA, miRNA and small
genes, in fact we have not lost the ability to express larger genes. Larger
genes can be split into multiple smaller segments that when expressed
will reconstitute in vivo to form a functional protein. The concept of
splitting genes has been studied for many decades, and one of the ﬁrst
reports involved splitting the gene encoding b-galactosidase.48 Other
examples of genes that have been split and reconstituted in vivo
include the genes encoding ubiquitin,49 PurN,50 adenylate kinase51
and the yellow ﬂuorescent protein, Venus.52 Because they are nearly
devoid of bacterial sequences, almost all of the Minivector is available
to encode a useful sequence. Even at 2000bp, Minivectors can encode
ap r o m o t e ra n dB1500bp of gene sequence (either an intact small
gene or gene fragment), signiﬁcantly increasing the arsenal of useful
therapeutic sequences.
To our knowledge, no previous study has investigated such a broad
range of DNA sizes and topologies as reported here. These data will be
useful for identifying the factors most important for resisting shear
forces involved in gene therapy delivery. Knowing how to mitigate
DNA vector degradation will facilitate the development of new, more
efﬁcacious gene therapy vectors. In addition, the use of the nebulizer
makes our data particularly germane to clinical applications. The
ability of Minivectors to resist shear forces associated with gene
therapy delivery renews hope of treating human diseases using DNA
vectors.
MATERIALS AND METHODS
Chemicals, reagents and equipment
Acrylamide was from EMD Chemicals (Gibbstown, NJ, USA), agarose from
ISC BioExpress (Kaysville, UT, USA) and SYBR Gold from Invitrogen
(Hercules, CA, USA). Restriction enzymes were from New England Biolabs
(Ipswich, MA, USA). All other chemicals were from Fisher Scientiﬁc (Waltham,
MA, USA). Plasmid Maxi kit was from Qiagen (Valencia, CA, USA) and
Amicon Ultra centrifugal ﬁlters were from Millipore (Billerica, MA, USA). The
Aerotech II jet nebulizer was from CSI-US Inc. (Bedford, MA, USA) and the
Aridyne 2000 compressor was from Allied Healthcare Products (St Louis, MO,
USA). The 1/8in probe sonicator (Model 60 Sonic Dismembrator) was from
Fisher Scientiﬁc. PC Image and Total Lab software were from Fotodyne
DNA shearing
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Gene Therapy(Hartland, WI, USA) and Total Lab (Durham, NC, USA), respectively.
KaleidaGraph (version 4.1) was from Synergy Software (Reading, PA, USA).
DNA generation and manipulation
DNA vectors used in this study are listed in Table 1. Throughout the text, we
refer to these by their length. Following the convention of using ‘p’ in front of
plasmid names, we designate Minivectors with ‘mv’. Parent plasmids used to
generate Minivectors are designated ‘pMV’. pMV-KB4TAL-GLuc and pMV-
CMV-GLuc were gifts from Dr Stephen Gottschalk (Baylor College of Medi-
cine, Houston, TX, USA) and pMV-CMV-Luc2 was a gift from Dr David
Spencer (Baylor College of Medicine). pMV-H1-miR31, pMV-KB4TAL-
mCherry and pMV-CMV-mCherry were gifts from Dr Martin M Matzuk
and Dr Zhifeng Yu (Baylor College of Medicine). pQR499 was a gift from
Dr John Ward (University College London, London, UK). pDJC1 was con-
structed by digesting pQR499 with TﬁIa n dAﬂIII. The recessed ends of the
digested pQR499 were ﬁlled in with T4 DNA polymerase and subsequently
ligated with T4 DNA ligase. Plasmids were generated in Escherichia coli DH5a
cells, isolated using a Plasmid Maxi kit as per the manufacturer’s instructions, and
subsequently desalted and concentrated using Amicon Ultra centrifugal ﬁlters.
Minivectors were obtained as follows. Minivector parent plasmids were
transformed into E. coli strain LZ54.30 Large-scale l Int-mediated recombina-
tion and Minivector isolation was performed as described.25,26 To generate
nicked DNA vector, nicking endonuclease Nt.BbvCI was used following the
manufacturer’s protocols. To obtain relaxed DNA, nicked DNA was religated
using T4 DNA ligase. Linearization was performed with either BspHI, EcoRV,
PvuIo rScaI, depending on which overhang end was desired, as per the
manufacturer’s protocols. Nicked, relaxed and linear DNAs were extracted with
phenol:chloroform:isoamyl alcohol (25:24:1), extracted with chloroform, and
precipitated with ethanol. Each DNA topology was resuspended in TE buffer
(10mM Tris-HCl, 1 mM EDTA, pH 8) and veriﬁed using gel electrophoresis
before nebulization or sonication.
DNA shearing
For nebulization, 10ml of DNA at 1mgml  1 in TE buffer was added to an
Aerotech II jet nebulizer. Air was delivered to the nebulizer at a rate of
10lmin 1 and gauge pressure of 50p.s.i. by an Aridyne 2000 compressor.
For the studies of the effects of DNA length on nebulization survival, 15ml
aliquots were removed from the nebulizer reservoir before and at intervals
throughout nebulization up to 30min, at which point the DNA solution was
depleted. Because of the dramatic changes that occurred early, aliquots were
taken at 1min intervals initially and at 2min intervals after 10min.
For sonication, 1ml of DNA at 1mgml  1 in TE buffer in a 1.7ml eppendorf
tube was incubated on ice during sonication with a 1/8in probe sonicator at
setting 5, which has an output of 3–7W (root mean square). For consistency,
the probe was inserted halfway down into the solution and the sides of the tube
were avoided. 15ml aliquots were removed before sonication and at the time
points indicated.
All DNA shearing experiments were performed a minimum of three separate
times. DNA was analyzed by electrophoresis on 1% agarose gels for 41000bp
or 2% agarose gels or 5% acrylamide (29:1 acrylamide:bis-acrylamide) gels for
o1000bp in 40mM Tris-acetate and 2mM EDTA. All gels were submitted to
125V for 2h, stained with SYBR Gold for 20min and visualized using PC
Image. Total Lab was utilized to quantify the remaining intact DNA. Data were
analyzed and ﬁtted using KaleidaGraph.
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